Praxis Precision Medicines, Inc. · NASDAQ:PRAX
Baker Bros. Advisors LP reported a 6.30% stake in Praxis Precision Medicines, Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed May 15, 2026
Baker Bros. Advisors LP reported a 6.30% stake in Praxis Precision Medicines, Inc., 1,753,198 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G).
- Stake
- 6.30%
- Shares
- 1,753,198
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Baker Bros. Advisors LP | 6.30% | 1,753,198 |
| Baker Bros. Advisors (GP) LLC | 6.30% | 1,753,198 |
| Julian C. Baker | 6.30% | 1,753,198 |
| Felix J. Baker | 6.30% | 1,753,198 |
Source
Related
- Praxis Precision Medicines, Inc.
- Baker Bros. Advisors LP
- Praxis Precision Medicines, Inc. shareholders
- Schedule 13G/A · Orbis Investment Management LTD · Aug 14, 2026
- Form 4 · Souza Marcio · Jul 8, 2026
- Form 4 · DeSimone Jill · Jun 26, 2026
- Form 4 · Arbuckle Stuart A · Jun 12, 2026
- Form 4 · Chodakewitz Jeffrey · Jun 12, 2026